SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-031579
Filing Date
2022-11-14
Accepted
2022-11-14 07:00:32
Documents
13
Period of Report
2022-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42057
2 ex10-56.htm EX-10.56 14749
  Complete submission text file 0001493152-22-031579.txt   231592

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bixt-20221028.xsd EX-101.SCH 3297
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bixt-20221028_lab.xml EX-101.LAB 34240
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bixt-20221028_pre.xml EX-101.PRE 22367
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3482
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 221380055
SIC: 2834 Pharmaceutical Preparations